CABA — CABALETTA BIO INC

Ownership history in FEDERATED HERMES, INC.  ·  13 quarters on record

This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in CABALETTA BIO INC (CABA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 112,028 -232,512 -67.5% 0.00% $262K $2.34
2025 Q2 ADDED 344,540 +1,129 +0.3% 0.00% $524K $1.52
2025 Q1 ADDED 343,411 +196,064 +133.1% 0.00% $476K $1.38
2024 Q4 ADDED 147,347 +146,959 +37876.0% 0.00% $334K $2.27
2024 Q3 ADDED 388 +256 +193.9% 0.00% $2K $4.72
2023 Q4 ADDED 132 +74 +127.6% 0.00% $3K $22.70
2023 Q3 REDUCED 58 -215 -78.8% 0.00% $883 $15.22
2023 Q2 REDUCED 273 -1,318 -82.8% 0.00% $4K $12.91
2022 Q3 ADDED 1,591 +434 +37.5% 0.00% $1K $0.65
2022 Q2 ADDED 1,157 +1,008 +676.5% 0.00% $1K $1.06
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CABA price (monthly, adj. close)

Other funds also holding CABA

As of 2025 Q4 — sorted by position size

SUPERSTRING CAPITAL MANAGEMENT LP 2.64% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.62% Cormorant Asset Management, LP 3Y 7Y 0.45% Stonepine Capital Management, LLC 3Y 7Y 0.27% Opaleye Management Inc. 3Y 7Y 0.26% Almitas Capital LLC 3Y 7Y 0.19% Ikarian Capital, LLC 3Y 0.15% Burkehill Global Management, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.06% 683 Capital Management, LLC 3Y 7Y 0.04%
← Back to FEDERATED HERMES, INC. Holdings